This session will provide an overview of the basics of Target-controlled infusion (TCI) technology including how pharmacokinetic (pK) models are developed and implemented and describe its use. The second part of the session will focus on the new Eleveld general purpose model for propofol, exploring its benefits for total intravenous anesthesia (TIVA).
After participating in this activity, participants will be able to:
